Literature DB >> 23604313

Elevation of urinary liver-type fatty acid-binding protein as predicting factor for occurrence of contrast-induced acute kidney injury and its reduction by hemodiafiltration with blood suction from right atrium.

Hiromasa Katoh1, Tsuyoshi Nozue, Yuya Kimura, Sei Nakata, Taku Iwaki, Mitsuhiro Kawano, Masa-Aki Kawashiri, Ichiro Michishita, Masakazu Yamagishi.   

Abstract

Although contrast-induced acute kidney injury (CI-AKI) has a great impact on patients' prognosis, few data exist regarding predictors of CI-AKI in patients with severe renal dysfunction who have undergone contrast angiography. Therefore, we prospectively studied 25 patients with renal dysfunction, which was defined as the estimated glomerular filtration rate (eGFR) level <45 ml/min/1.73 m(2), undergoing coronary angiography (CAG) or percutaneous coronary intervention (PCI). We performed hemodiafiltration with blood suction from the right atrium (RA-HDF). The mean level of urinary liver-type fatty acid-binding protein (L-FABP) at baseline was significantly higher in the CI-AKI group than in the non-CI-AKI group (59.8 ± 45.6 vs 13.4 ± 11.9 μg/gCr, P = 0.0003). Multivariate regression analysis demonstrated that baseline urinary L-FABP was an independent significant predictor of CI-AKI (β = 0.741, P = 0.013). Receiver-operating characteristic analysis showed that baseline urinary L-FABP exhibited 100 % sensitivity and 81.8 % specificity for predicting CI-AKI when the cutoff value was defined as 19.0 μg/gCr. Interestingly, the incidence of CI-AKI after CAG or PCI was reduced in the RA-HDF group in a comparison with 41 control patients (12 % vs 27 %) with eGFR level <45 ml/min/1.73 m(2) who underwent PCI before the introduction of RA-HDF. In conclusion, baseline L-FABP levels can be a predictor for occurrence of CI-AKI. We suggest that RA-HDF may prevent the development of CI-AKI in patients with severe renal dysfunction undergoing coronary procedures, although further large-scale prospective study is necessary to confirm our conclusions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23604313     DOI: 10.1007/s00380-013-0347-9

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  30 in total

1.  The serum cystatin C concentration measured by particle-enhanced immunonephelometry is well correlated with inulin clearance in patients with various types of glomerulonephritis.

Authors:  T Hayashi; K Nitta; M Hatano; M Nakauchi; H Nihei
Journal:  Nephron       Date:  1999       Impact factor: 2.847

Review 2.  Structural and functional features of different types of cytoplasmic fatty acid-binding proteins.

Authors:  J H Veerkamp; R A Peeters; R G Maatman
Journal:  Biochim Biophys Acta       Date:  1991-01-04

3.  Association between deteriorated renal function and long-term clinical outcomes after percutaneous coronary intervention.

Authors:  Manabu Ogita; Kenichi Sakakura; Tomohiro Nakamura; Hiroshi Funayama; Hiroshi Wada; Ryo Naito; Yoshitaka Sugawara; Norifumi Kubo; Junya Ako; Shin-ichi Momomura
Journal:  Heart Vessels       Date:  2011-08-06       Impact factor: 2.037

4.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality.

Authors:  P A McCullough; R Wolyn; L L Rocher; R N Levin; W W O'Neill
Journal:  Am J Med       Date:  1997-11       Impact factor: 4.965

5.  Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful.

Authors:  B Vogt; P Ferrari; C Schönholzer; H P Marti; M Mohaupt; M Wiederkehr; C Cereghetti; A Serra; U Huynh-Do; D Uehlinger; F J Frey
Journal:  Am J Med       Date:  2001-12-15       Impact factor: 4.965

6.  The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency.

Authors:  L Gruberg; G S Mintz; R Mehran; G Gangas; A J Lansky; K M Kent; A D Pichard; L F Satler; M B Leon
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

7.  Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy.

Authors:  Tsukasa Nakamura; Takeshi Sugaya; Koichi Node; Yoshihiko Ueda; Hikaru Koide
Journal:  Am J Kidney Dis       Date:  2006-03       Impact factor: 8.860

8.  Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease.

Authors:  Atsuko Kamijo; Kenjiro Kimura; Takeshi Sugaya; Masaya Yamanouchi; Akihisa Hikawa; Norihito Hirano; Yasunobu Hirata; Atsuo Goto; Masao Omata
Journal:  J Lab Clin Med       Date:  2004-01

9.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

10.  The prevention of radiocontrast-agent-induced nephropathy by hemofiltration.

Authors:  Giancarlo Marenzi; Ivana Marana; Gianfranco Lauri; Emilio Assanelli; Marco Grazi; Jeness Campodonico; Daniela Trabattoni; Franco Fabbiocchi; Piero Montorsi; Antonio L Bartorelli
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

View more
  6 in total

1.  Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography.

Authors:  Isidro Torregrosa; Carmina Montoliu; Amparo Urios; María Jesús Andrés-Costa; Carla Giménez-Garzó; Isabel Juan; María Jesús Puchades; María Luisa Blasco; Arturo Carratalá; Rafael Sanjuán; Alfonso Miguel
Journal:  Heart Vessels       Date:  2014-07-03       Impact factor: 2.037

2.  Contrast between innovator drug- and generic drug-induced renal dysfunction on coronary angiography (CONTRAST study).

Authors:  Ayumi Nakamura; Shin-Ichiro Miura; Makoto Sugihara; Yuiko Miyase; Kenji Norimatsu; Yuhei Shiga; Hiroaki Nishikawa; Keijiro Saku
Journal:  Heart Vessels       Date:  2013-09-27       Impact factor: 2.037

3.  Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease.

Authors:  Daishi Fujita; Masao Takahashi; Kent Doi; Mitsuru Abe; Junichi Tazaki; Arihiro Kiyosue; Masahiro Myojo; Jiro Ando; Hideo Fujita; Eisei Noiri; Takeshi Sugaya; Yasunobu Hirata; Issei Komuro
Journal:  Heart Vessels       Date:  2014-02-20       Impact factor: 2.037

Review 4.  Renalase and Biomarkers of Contrast-Induced Acute Kidney Injury.

Authors:  Maciej T Wybraniec; Katarzyna Mizia-Stec
Journal:  Cardiorenal Med       Date:  2015-09-19       Impact factor: 2.041

5.  Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2.

Authors:  Yoshiteru Maeda; Atsushi Suzuki; Junnichi Ishii; Sahoko Sekiguchi-Ueda; Megumi Shibata; Yasumasa Yoshino; Shogo Asano; Nobuki Hayakawa; Kazuhiro Nakamura; Yasukazu Akiyama; Fumihiko Kitagawa; Toshiaki Sakuishi; Takashi Fujita; Shuji Hashimoto; Yukio Ozaki; Mitsuyasu Itoh
Journal:  Heart Vessels       Date:  2014-03-14       Impact factor: 2.037

6.  Urinary neutrophil gelatinase-associated lipocalin as a predictor of cardiovascular events in patients with chronic kidney disease.

Authors:  Midori Hasegawa; Junichi Ishii; Fumihiko Kitagawa; Kazuo Takahashi; Hiroki Hayashi; Shigehisa Koide; Makoto Tomita; Hiroshi Takahashi; Yukio Ozaki; Yukio Yuzawa
Journal:  Heart Vessels       Date:  2013-12-31       Impact factor: 2.037

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.